Drug Shortage Report for ISOFLURANE USP
Report ID | 234163 |
Drug Identification Number | 02237518 |
Brand name | ISOFLURANE USP |
Common or Proper name | ISOFLURANE USP |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | ISOFLURANE |
Strength(s) | 99.9% |
Dosage form(s) | LIQUID |
Route of administration | INHALATION INHALATION |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 250 mL (Veterinary) |
ATC code | |
ATC description | |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2024-07-30 |
Estimated end date | 2024-08-28 |
Actual end date | 2024-08-09 |
Shortage status | Resolved |
Updated date | 2024-08-10 |
Company comments | Fresenius Kabi Canada regrets to advise that due to unforeseen circumstances, we will be encountering a supply interruption on the below Isoflurane USP 99.9% product formats effective July 30, 2024, until August 28, 2024. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-08-10 | English | Compare |
v4 | 2024-08-09 | French | Compare |
v3 | 2024-08-09 | English | Compare |
v2 | 2024-07-31 | French | Compare |
v1 | 2024-07-31 | English | Compare |
Showing 1 to 5 of 5